Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphomaMatthew J. Frigault, Marcela V. Maus, Jörg Dietrich et al.|Blood|2019Cited by 237
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantationPhilippe Armand, Alex F. Herrera, Yi‐Bin Chen et al.|Blood|2019Cited by 187
Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapyJennifer L. Crombie, Michael Dickinson, Tara Graff et al.|Blood|2024Cited by 132
The treatment of Burkitt lymphoma in adultsJennifer L. Crombie, Ann S. LaCasce|Blood|2020Cited by 105
Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative DisordersJennifer L. Crombie, Ann S. LaCasce|Frontiers in Oncology|2019Cited by 104